PHGE - יחס חוב להיוון בספרים biomx.com

BiomX Inc. (PHGE) holds the status of an innovator in the treatment of severe infections, sparking optimism among medical professionals. The ratio of total debt to balance sheet capital demonstrates current financial stability, with the indicator standing at 0.32. BiomX Inc. (PHGE) minimizes operational risks through CDMO manufacturing, while strategic alliances with research centers enable the creation of alternatives to traditional antibiotics.

BiomX Inc. is developing the unique BOLT platform to create custom bacteriophages that replace traditional antibiotics. Scaling such innovations requires a balance between equity and debt. This ratio compares total debt to the book value of assets, determining financial stability and the resource base. Low values eliminate default risk but may limit the pace of expansion. The history of leverage relative to capitalization clearly demonstrates this strategic dependency.